Marksans Pharma Limited has informed the Exchange regarding a press release dated March 19, 2025, titled "Marksans Pharma Limited s wholly owned subsidiary in the UK, Relonchem Limited receives Marketing Authorization for the product Baclofen 10 mg Tablets from UK MHRA".